— Know what they know.
Not Investment Advice

CYDX OTC

CYduct Diagnostics, Inc.
1W: +9.3% 1M: -57.3% 3M: +19.1% YTD: +146.2% 1Y: +112.9% 3Y: +24.4% 5Y: -60.0%
$0.50
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Devices · Tech Score Strong Sell · Power 37 · $2.6M mcap · 5M float · 0.035% daily turnover · Short 57% of daily vol

Cash Flow Trends

Operating Cash Flow
-$72K +34.5% ▲
Capital Expenditures
$0 -25.0% ▼
Free Cash Flow
-$72K +34.5% ▲
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$29K +88.5% ▲

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$372K-$420K-$473K-$418K-$414K
Depreciation & Amort.$0$0$0$0$0
Stock-Based Comp.$0$0$0$0$0
Change in Working Capital$253K$293K$206K$243K$342K
Other Non-Cash Items$62K$0$0$0$0
Operating Cash Flow-$58K-$128K-$267K-$175K-$72K
— Investing Activities —
Capital Expenditures$0$0$4$3$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases$0$0$0$0$0
Investment Sales$0$0$0$0$0
Other Investing$0$0-$4-$194$0
Investing Cash Flow$0$0$0-$191$0
— Financing Activities —
Net Debt Issuance$0$380K$50K$100K$43K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$0$0$0
Financing Cash Flow$0$380K$50K$150K$43K
Net Change in Cash$553$253K-$217K-$25K-$29K
Cash End of Period$19K$272K$55K$30K$1K
Free Cash Flow-$58K-$128K-$267K-$175K-$72K

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms